Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
8 pending office actions • 5 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Paul Scherrer Institut has 8 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 8 distinct examiners and 5 distinct art units. This indicates broad examiner distribution with recurring art-unit assignments across the pending portfolio.
BROWN, MINDY G is the busiest examiner, with 1 pending action. Counsel may benefit from coordinating substantive positions across related art-unit matters while preserving separate examiner-specific response planning.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §103 only | 2 (25%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 4 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BROWN, MINDY G | 1 | 57.8% | +40.5% |
| XIAO, YAN | 1 | 67.3% | +52.7% |
| TAYLOR, JORDAN W | 1 | 63.2% | +36.9% |
| ROGERS, JAMES WILLIAM | 1 | 46.1% | +22.4% |
| BLACKWELL-RUDASIL, RYAN KENZIE | 1 | 60.9% | +35.7% |
| WESTERBERG, NISSA M | 1 | 23.4% | +37.3% |
| SCHLIENTZ, LEAH H | 1 | 41.8% | +38.7% |
| YOUNG, MICAH PAUL | 1 | 55.2% | +30.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18696532 | METHOD FOR PREDICTING THE RESPONSE OF A PATIENT DIAGNOSED WITH CANCER TO TREATMENT AND/OR IMAGING WITH A COMPOUND TARGETING CCK2-R, AND COMPOUND FOR USE IN METHODS OF SELECTIVELY TREATING AND/OR IMAGING CANCER | BROWN, MINDY G | — |
| 18604709 | TRANSGLUTAMINASE CONJUGATION METHOD AND LINKER | XIAO, YAN | — |
| 18566216 | Isolated Metal Species in Metal-Zeolite Catalytic Material for Low Temperature SCR of NOx with NH3 | TAYLOR, JORDAN W | — |
| 18552124 | [161Tb]-BASED RADIOPEPTIDES | ROGERS, JAMES WILLIAM | — |
| 18041571 | A METHOD FOR PREPARING NANOMETER-SIZED SURFACE FLUORINATED BATTERY MATERIALS | BLACKWELL-RUDASIL, RYAN KENZIE | — |
| 18040021 | ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASES | WESTERBERG, NISSA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18040024 | GALLIUM-LABELED GASTRIN ANALOGUE AND USE IN A METHOD OF IMAGING CCKB-RECEPTOR-POSITIVE TUMORS OR CANCERS | YOUNG, MICAH PAUL | 8d |
| 18040011 | COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS | SCHLIENTZ, LEAH H | 26d |
| 18696532 | METHOD FOR PREDICTING THE RESPONSE OF A PATIENT DIAGNOSED WITH CANCER TO TREATMENT AND/OR IMAGING WITH A COMPOUND TARGETING CCK2-R, AND COMPOUND FOR USE IN METHODS OF SELECTIVELY TREATING AND/OR IMAGING CANCER | BROWN, MINDY G | — |
| 18604709 | TRANSGLUTAMINASE CONJUGATION METHOD AND LINKER | XIAO, YAN | — |
| 18566216 | Isolated Metal Species in Metal-Zeolite Catalytic Material for Low Temperature SCR of NOx with NH3 | TAYLOR, JORDAN W | — |
| 18552124 | [161Tb]-BASED RADIOPEPTIDES | ROGERS, JAMES WILLIAM | — |
| 18041571 | A METHOD FOR PREPARING NANOMETER-SIZED SURFACE FLUORINATED BATTERY MATERIALS | BLACKWELL-RUDASIL, RYAN KENZIE | — |
| 18040021 | ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASES | WESTERBERG, NISSA M | — |
| Art Unit | Apps |
|---|---|
| 1618 | 4 |
| 1683 | 1 |
| 1642 | 1 |
| 1738 | 1 |
| 1722 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18696532 | METHOD FOR PREDICTING THE RESPONSE OF A PATIENT DIAGNOSED WITH CANCER TO TREATMENT AND/OR IMAGING WITH A COMPOUND TARGETING CCK2-R, AND COMPOUND FOR USE IN METHODS OF SELECTIVELY TREATING AND/OR IMAGING CANCER | BROWN, MINDY G | 1683 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18604709 | TRANSGLUTAMINASE CONJUGATION METHOD AND LINKER | XIAO, YAN | 1642 | §102§112Other | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18566216 | Isolated Metal Species in Metal-Zeolite Catalytic Material for Low Temperature SCR of NOx with NH3 | TAYLOR, JORDAN W | 1738 | §102§103§112 | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18552124 | [161Tb]-BASED RADIOPEPTIDES | ROGERS, JAMES WILLIAM | 1618 | §102§103 | Non-Final OA | — | Pending | Sep 22, 2023 |
| 18041571 | A METHOD FOR PREPARING NANOMETER-SIZED SURFACE FLUORINATED BATTERY MATERIALS | BLACKWELL-RUDASIL, RYAN KENZIE | 1722 | §103§112 | Non-Final OA | — | Pending | Feb 14, 2023 |
| 18040021 | ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASES | WESTERBERG, NISSA M | 1618 | §103DP | Non-Final OA | — | Pending | Jan 31, 2023 |
| 18040011 | COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS | SCHLIENTZ, LEAH H | 1618 | §103 | Final Rejection | 26d | Pending | Jan 31, 2023 |
| 18040024 | GALLIUM-LABELED GASTRIN ANALOGUE AND USE IN A METHOD OF IMAGING CCKB-RECEPTOR-POSITIVE TUMORS OR CANCERS | YOUNG, MICAH PAUL | 1618 | §103 | Final Rejection | 8d | Pending | Jan 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPaul Scherrer Institut has 8 pending office actions as of October 2026, spread across 5 art units and 8 examiners.
Mindy G Brown has the most, with 1 of Paul Scherrer Institut's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
